Regeneron Pharmaceuticals, Inc. (0R2M)
Market Closed
16 Dec, 16:20
$
747. 84
-7.94
-1.05%
$
- Market Cap
24.52 P/E Ratio
0% Div Yield
191 Volume
42.79 Eps
$ 755.78
Previous Close Day Range
738.59 764.99
Year Range
689 998.57
Want to track 0R2M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 48 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. 3 Feb 2026 (In 1 month) | | 10.65 | - |
| REGN Regeneron Pharmaceuticals, Inc. 30 Jan 2026 (In 1 month) | | 9.26 | - |
| REGN Regeneron Pharmaceuticals, Inc. 30 Oct 2025 | | 9.67 | 11.83 |
| REGN Regeneron Pharmaceuticals, Inc. 29 Oct 2025 | | - | - |
| REGN Regeneron Pharmaceuticals, Inc. 30 Jul 2025 | | 8.53 | 12.89 |
| REGN Regeneron Pharmaceuticals, Inc. 30 Apr 2025 | | - | - |
| REGN Regeneron Pharmaceuticals, Inc. 31 Jan 2025 | | 11.38 | 12.07 |
| REGN Regeneron Pharmaceuticals, Inc. 31 Oct 2024 | | 11.69 | 12.46 |
| REGN Regeneron Pharmaceuticals, Inc. 1 Aug 2024 | | 10.61 | 11.56 |
| REGN Regeneron Pharmaceuticals, Inc. 2 May 2024 | | 10.09 | 9.55 |
| REGN Regeneron Pharmaceuticals, Inc. 2 Feb 2024 | | 10.73 | 11.86 |
| REGN Regeneron Pharmaceuticals, Inc. 2 Nov 2023 | | 10.72 | 11.59 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2016 | | 2.71 | 3.13 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Aug 2016 | | 2.65 | 2.82 |
| REGN Regeneron Pharmaceuticals, Inc. 5 May 2016 | | 2.58 | 2.57 |
| REGN Regeneron Pharmaceuticals, Inc. 9 Feb 2016 | | 3.36 | 2.83 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2015 | | 3.2 | 3.47 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Aug 2015 | | 2.77 | 2.89 |
| REGN Regeneron Pharmaceuticals, Inc. 7 May 2015 | | 2.68 | 2.88 |
| REGN Regeneron Pharmaceuticals, Inc. 10 Feb 2015 | | 2.82 | 2.79 |
| REGN Regeneron Pharmaceuticals, Inc. 4 Nov 2014 | | 2.57 | 2.52 |
| REGN Regeneron Pharmaceuticals, Inc. 5 Aug 2014 | | 2.29 | 2.47 |
| REGN Regeneron Pharmaceuticals, Inc. 8 May 2014 | | 2.2 | 2.26 |
| REGN Regeneron Pharmaceuticals, Inc. 11 Feb 2014 | | 0.98 | 0.86 |
| REGN Regeneron Pharmaceuticals, Inc. 5 Nov 2013 | | 0.9 | 1.25 |
| REGN Regeneron Pharmaceuticals, Inc. 6 Aug 2013 | | 0.88 | 0.79 |
| REGN Regeneron Pharmaceuticals, Inc. 3 May 2013 | | 0.98 | 0.9 |
| REGN Regeneron Pharmaceuticals, Inc. 14 Feb 2013 | | 1.1 | 1.22 |
0R2M Earnings Reports FAQ
What is the earnings per share (EPS) for 0R2M?
The current EPS is 42.79.
What is the company's earnings growth rate?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-02, based on the 0R2M's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Regeneron Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0R2M at this time, as Regeneron Pharmaceuticals, Inc has no recent EPS data to calculate it.
